Abstract:G protein-coupled receptor 30 (GPR30) is a membrane receptor reported to bind 17β-estradiol (E2) and mediate rapid nongenomic estrogen responses, hence also named G protein-coupled estrogen receptor. G-1 is a proposed GPR30-specific agonist that has been used to implicate the receptor in several pathophysiological events. However, controversy surrounds the role of GPR30 in G-1 and E2 responses. We investigated GPR30 activity in the absence and presence of G-1 and E2 in several eukaryotic systems ex vivo and in vitro in the absence and presence of the receptor. Ex vivo activity was addressed using the caudal artery from wild-type (WT) and GPR30 knockout (KO) mice, and in vitro activity was addressed using a HeLa cell line stably expressing a synthetic multifunctional promoter (nuclear factor κB, signal transducer and activator of transcription, activator protein 1)-luciferase construct (HFF11 cells) and a human GPR30-inducible T-REx system (T-REx HFF11 cells), HFF11 and human embryonic kidney 293 cells transiently expressing WT GPR30 and GPR30 lacking the C-terminal PDZ (postsynaptic density-95/discs-large /zonula occludens-1 homology) motif SSAV, and yeast Saccharomyces cerevisiae transformed to express GPR30. WT and KO arteries exhibited similar contractile responses to 60 mM KCl and 0.3 μM cirazoline, and G-1 relaxed both arteries with the same potency and efficacy. Furthermore, expression of GPR30 did not introduce any responses to 1 μM G-1 and 0.1 μM E2 in vitro. On the other hand, receptor expression caused considerable ligand-independent activity in vitro, which was receptor PDZ motif-dependent in mammalian cells. We conclude from these results that GPR30 exhibits ligand-independent activity in vitro but no G-1- or E2-stimulated activity in any of the systems used. SIGNIFICANCE STATEMENT: Much controversy surrounds 17β-estradiol (E2) and G-1 as G protein-coupled receptor 30 (GPR30) agonists. We used several recombinant eukaryotic systems ex vivo and in vitro with and without GPR30 expression to address the role of this receptor in responses to these proposed agonists. Our results show that GPR30 exhibits considerable ligand-independent activity in vitro but no G-1- or E2-stimulated activity in any of the systems used. Thus, classifying GPR30 as an estrogen receptor and G-1 as a specific GPR30 agonist is unfounded.

G protein-coupled estrogen receptor 1 expression in human vocal fold.

[Expression of Transforming Growth Factor Beta1 in Human Vocal Fold Polyps].

Expression Of G Protein-Coupled Estrogen Receptor In Gastric Cancer Tissues

Estrogen Receptor Beta Variants Mrna Expressions in Gastric Cancer Tissues and Association with Clinicopathologic Parameters

Expression of G Protein-Coupled Receptor 30 in the Hamster Ovary: Differential Regulation by Gonadotropins and Steroid Hormones

Histologic distribution, fragment cloning, and sequence analysis of g protein couple receptor 30 in rat submaxillary gland.

Localization of Estrogen Receptor ERα, ERβ and GPR30 on Myenteric Neurons of the Gastrointestinal Tract and Their Role in Motility.

[Expression of Vascular Endothelial Growth Factor and Its Receptors in Laryngeal Carcinoma Cell and Its Significance].

[Expressions of Protease-Activated Receptors in Human Gingival Fibroblasts and Its Functions in Periodontitis].

Mechanisms Underlying the Antifibrotic Potential of Estradiol for Vocal Fold Fibrosis

Ligand-Independent G Protein-Coupled Estrogen Receptor/G Protein-Coupled Receptor 30 Activity: Lack of Receptor-Dependent Effects of G-1 and 17 β-Estradiol

G Protein-Coupled Receptor 30 Expression is Required for Estrogen Stimulation of Primordial Follicle Formation in the Hamster Ovary

The expression and significance of estrogen transmembrane receptor GPR30 in endometrial carcinoma

Reevaluating GPR30: A Paradigm Shift from Estrogen Receptor to Unique Hydrophilic Ligand Activation

Multiplex G Protein-Coupled Receptor Screen Reveals Reliably Acting Agonists and a Gq-Phospholipase C Coupling Mode of GPR30/GPER1

Cellular and Molecular Effects of Steroid Sex Hormones on the Vocal Folds: A Scoping Review

Expression of Epidermal Growth Factor Receptor Variant Iii in Laryngeal Carcinoma Tissues

GPRC5A: an Emerging Biomarker in Human Cancer

Structural and Functional Evidence That GPR30 is Not a Direct Estrogen Receptor

Involvement of estrogen receptor variant ER-alpha36, not GPR30, in nongenomic estrogen signaling.

Expression of Orphan GPR56 Correlates with Tumor Progression in Human Epithelial Ovarian Cancer.